5.954
Precedente Chiudi:
$5.79
Aprire:
$5.87
Volume 24 ore:
36,175
Relative Volume:
0.82
Capitalizzazione di mercato:
$828.51M
Reddito:
$9.96M
Utile/perdita netta:
$-199.33M
Rapporto P/E:
-1.7866
EPS:
-3.3326
Flusso di cassa netto:
$-93.38M
1 W Prestazione:
+7.86%
1M Prestazione:
-3.81%
6M Prestazione:
+102.52%
1 anno Prestazione:
+234.49%
Inventiva Adr Stock (IVA) Company Profile
Confronta IVA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IVA
Inventiva Adr
|
5.954 | 805.16M | 9.96M | -199.33M | -93.38M | -3.3326 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
403.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
605.84 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
459.38 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
768.65 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
343.93 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-03 | Ripresa | H.C. Wainwright | Buy |
2025-08-27 | Iniziato | Piper Sandler | Overweight |
2025-02-21 | Iniziato | TD Cowen | Buy |
2024-11-12 | Iniziato | UBS | Neutral |
2023-10-27 | Iniziato | Canaccord Genuity | Buy |
2023-05-31 | Iniziato | ROTH MKM | Buy |
2023-05-19 | Aggiornamento | Societe Generale | Sell → Buy |
2023-03-17 | Iniziato | Stifel | Buy |
2022-11-15 | Downgrade | Societe Generale | Buy → Sell |
2021-03-08 | Downgrade | Societe Generale | Buy → Sell |
2020-08-05 | Iniziato | ROTH Capital | Buy |
2020-08-04 | Iniziato | Guggenheim | Buy |
2020-08-04 | Iniziato | Stifel | Buy |
Mostra tutto
Inventiva Adr Borsa (IVA) Ultime notizie
Inventiva Appoints Andrew Obenshain as Chief Executive Officer - GlobeNewswire Inc.
Inventiva (NASDAQ:IVA) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Inventiva SA Reports Progress and Challenges in 2025 - TipRanks
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Inventiva (NASDAQ:IVA) Shares Gap UpHere's What Happened - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $14.83 Average Target Price from Analysts - Defense World
Inventiva (NASDAQ:IVA) Shares Gap DownTime to Sell? - MarketBeat
Brokerages Set Inventiva S.A. Sponsored ADR (NASDAQ:IVA) PT at $14.83 - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Sees Significant Growth in Short Interest - MarketBeat
Inventiva (IVA) to Release Quarterly Earnings on Thursday - Defense World
Inventiva (NASDAQ:IVA) Shares Gap Down – Should You Sell? - Defense World
Brokers Set Expectations for Inventiva FY2025 Earnings - MarketBeat
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Increases By 188.0% - MarketBeat
Inventiva (NASDAQ:IVA) Shares Gap Up After Analyst Upgrade - MarketBeat
Inventiva (NASDAQ:IVA) Sees Large Volume Increase Following Analyst Upgrade - MarketBeat
Inventiva (NASDAQ:IVA) Earns Buy Rating from Analysts at HC Wainwright - Defense World
HC Wainwright Forecasts Inventiva FY2025 Earnings - Defense World
American Outdoor Brands Posts Downbeat Results, Joins Lululemon, Quanex Building And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva (NASDAQ:IVA) Price Target Raised to $13.00 at Guggenheim - Defense World
Why Did Inventiva Stock Plunge 10.82%? - AInvest
Inventiva (NASDAQ:IVA) Shares Gap Down – Here’s What Happened - Defense World
Inventiva (NASDAQ:IVA) Trading Up 4.3%Should You Buy? - MarketBeat
Inventiva (NASDAQ:IVA) Earns Overweight Rating from Analysts at Piper Sandler - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $10.40 Average Price Target from Brokerages - Defense World
How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79% - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Inventiva (NASDAQ:IVA) Trading 4.3% Higher – What’s Next? - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Shares in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) - Defense World
Rokmaster Resources (CVE:RKR) Stock Price Up 71.4% – Still a Buy? - Defense World
Portofino Resources (CVE:POR) Trading Up 100% – Should You Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Stock Price Up 25% – Time to Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Shares Up 25% – Here’s Why - Defense World
Portofino Resources (CVE:POR) Stock Price Up 100% – Time to Buy? - Defense World
Honey Badger Silver (CVE:TUF) Trading Down 12% – Here’s What Happened - Defense World
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% – Here’s Why - Defense World
Inventiva (NASDAQ:IVA) Trading 2.7% Higher – Here’s Why - Defense World
Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Inventiva sets share repurchase program terms post-meeting - Investing.com
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks
Stifel maintains Buy on Inventiva shares with $17 target - Investing.com
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks
Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com
Inventiva Adr Azioni (IVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):